PACAP-38, but not the related peptide VIP, induces migraine headache in migraineurs suggesting the specific PACAP-receptor, PAC1, as a potential target for migraine treatment (Rahmann et al., 2008; Schytz et al., 2009). This evidence concerns the gene VIP and Headache.